Global Extracellular Matrix (ECM) Patches

Extracellular Matrix (ECM) Patches Comprehensive Study by Type (Bovine, Porcine, Others), Application (Vascular Repair and Reconstruction, Cardiac Repair, Pericardial Repair, Dural Repair, Soft Tissue Repair, Wound Healing), End User (Hospitals, Surgical Clinics, Others) Players and Region - Global Market Outlook to 2030

Extracellular Matrix (ECM) Patches Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 8.06%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Extracellular Matrix (ECM) Patches
Extracellular Matrix (ECM) Patches are used to patch for cardiac and vascular tissue repair. ECM promotes a regenerative or healing pathway and facilitates tissue remodeling. It is used to support tissues segregating one another and regulate intercellular communication. These patches are useful for cardiac reconstruction in both animals and humans. The increasing use of extracellular matrix (ECM) patches for soft tissue repair and wound healing procedures has driven the market demand.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)
CAGR8.06%


The ECM Patches market is projected to experience significant growth in the coming years, driven by rising demand for minimally invasive procedures, aging populations, and increasing awareness of regenerative medicine options. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Smith & Nephew plc (United Kingdom), Boston Scientific Corporation (United States), Koninklijke DSM N.V. (Netherlands), Coloplast A/S (Denmark), Cook Group (United States), MTF Biologics (United States), Medtronic plc (Ireland), Baxter International Inc. (United States), Aziyo Biologics, Inc. (United States) and Admedus Ltd. (Australia) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are JZ Healthcare (Shanghai) Co., Ltd. (China), Orthox Regenerative Technologies Plc (United Kingdom), Medtronic China (China) and KCI Licensing Inc. (Texas).

Segmentation Overview
AMA Research has segmented the market of Global Extracellular Matrix (ECM) Patches market by Type (Bovine, Porcine and Others), Application (Vascular Repair and Reconstruction, Cardiac Repair, Pericardial Repair, Dural Repair, Soft Tissue Repair and Wound Healing) and Region.



On the basis of geography, the market of Extracellular Matrix (ECM) Patches has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by , the sub-segment i.e. will boost the Extracellular Matrix (ECM) Patches market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Trend for Bovine-based ECM Patches

Market Growth Drivers:
Increasing Incidence of Congenital Heart Disease (CHD) and Adoption of ECM in Hernia and Pelvic Reconstruction Surgeries

Challenges:
Lack of Skilled Professionals

Restraints:
High Cost of ECM Procedure

Opportunities:
Awareness Regarding Biological Patches, Rising Prevalence of Trauma and Hernia Repair Surgeries and Increasing Number of Surgeries in Emerging Countries

Market Leaders and their expansionary development strategies
In November 2023, A tissue bank partnered with a biotechnology company to develop and commercialize ECM patches derived from ethically sourced human adipose tissue for diverse regenerative applications.
In October 2023, Organogenesis Inc. launched its "PureSkin Dermal Repair Matrix," offering a decellularized dermal ECM patch for facial and body scar revision with minimal donor site morbidity.


Key Target Audience
New Entrants/Investors, Analysts and Strategic Business Planners, Extracellular Matrix (ECM) Patches Manufacturer, Raw Material Suppliers, Government Regulatory and Research Organizations

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Bovine
  • Porcine
  • Others
By Application
  • Vascular Repair and Reconstruction
  • Cardiac Repair
  • Pericardial Repair
  • Dural Repair
  • Soft Tissue Repair
  • Wound Healing
By End User
  • Hospitals
  • Surgical Clinics
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Incidence of Congenital Heart Disease (CHD)
      • 3.2.2. Adoption of ECM in Hernia and Pelvic Reconstruction Surgeries
    • 3.3. Market Challenges
      • 3.3.1. Lack of Skilled Professionals
    • 3.4. Market Trends
      • 3.4.1. Trend for Bovine-based ECM Patches
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Extracellular Matrix (ECM) Patches, by Type, Application, End User and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Extracellular Matrix (ECM) Patches (Value)
      • 5.2.1. Global Extracellular Matrix (ECM) Patches by: Type (Value)
        • 5.2.1.1. Bovine
        • 5.2.1.2. Porcine
        • 5.2.1.3. Others
      • 5.2.2. Global Extracellular Matrix (ECM) Patches by: Application (Value)
        • 5.2.2.1. Vascular Repair and Reconstruction
        • 5.2.2.2. Cardiac Repair
        • 5.2.2.3. Pericardial Repair
        • 5.2.2.4. Dural Repair
        • 5.2.2.5. Soft Tissue Repair
        • 5.2.2.6. Wound Healing
      • 5.2.3. Global Extracellular Matrix (ECM) Patches by: End User (Value)
        • 5.2.3.1. Hospitals
        • 5.2.3.2. Surgical Clinics
        • 5.2.3.3. Others
      • 5.2.4. Global Extracellular Matrix (ECM) Patches Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Extracellular Matrix (ECM) Patches: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Smith & Nephew plc (United Kingdom)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Boston Scientific Corporation (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Koninklijke DSM N.V. (Netherlands)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Coloplast A/S (Denmark)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Cook Group (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. MTF Biologics (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Medtronic plc (Ireland)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Baxter International Inc. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Aziyo Biologics, Inc. (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Admedus Ltd. (Australia)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Extracellular Matrix (ECM) Patches Sale, by Type, Application, End User and Region (value) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Extracellular Matrix (ECM) Patches (Value)
      • 7.2.1. Global Extracellular Matrix (ECM) Patches by: Type (Value)
        • 7.2.1.1. Bovine
        • 7.2.1.2. Porcine
        • 7.2.1.3. Others
      • 7.2.2. Global Extracellular Matrix (ECM) Patches by: Application (Value)
        • 7.2.2.1. Vascular Repair and Reconstruction
        • 7.2.2.2. Cardiac Repair
        • 7.2.2.3. Pericardial Repair
        • 7.2.2.4. Dural Repair
        • 7.2.2.5. Soft Tissue Repair
        • 7.2.2.6. Wound Healing
      • 7.2.3. Global Extracellular Matrix (ECM) Patches by: End User (Value)
        • 7.2.3.1. Hospitals
        • 7.2.3.2. Surgical Clinics
        • 7.2.3.3. Others
      • 7.2.4. Global Extracellular Matrix (ECM) Patches Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Extracellular Matrix (ECM) Patches: by Type(USD Million)
  • Table 2. Extracellular Matrix (ECM) Patches Bovine , by Region USD Million (2018-2023)
  • Table 3. Extracellular Matrix (ECM) Patches Porcine , by Region USD Million (2018-2023)
  • Table 4. Extracellular Matrix (ECM) Patches Others , by Region USD Million (2018-2023)
  • Table 5. Extracellular Matrix (ECM) Patches: by Application(USD Million)
  • Table 6. Extracellular Matrix (ECM) Patches Vascular Repair and Reconstruction , by Region USD Million (2018-2023)
  • Table 7. Extracellular Matrix (ECM) Patches Cardiac Repair , by Region USD Million (2018-2023)
  • Table 8. Extracellular Matrix (ECM) Patches Pericardial Repair , by Region USD Million (2018-2023)
  • Table 9. Extracellular Matrix (ECM) Patches Dural Repair , by Region USD Million (2018-2023)
  • Table 10. Extracellular Matrix (ECM) Patches Soft Tissue Repair , by Region USD Million (2018-2023)
  • Table 11. Extracellular Matrix (ECM) Patches Wound Healing , by Region USD Million (2018-2023)
  • Table 12. Extracellular Matrix (ECM) Patches: by End User(USD Million)
  • Table 13. Extracellular Matrix (ECM) Patches Hospitals , by Region USD Million (2018-2023)
  • Table 14. Extracellular Matrix (ECM) Patches Surgical Clinics , by Region USD Million (2018-2023)
  • Table 15. Extracellular Matrix (ECM) Patches Others , by Region USD Million (2018-2023)
  • Table 16. South America Extracellular Matrix (ECM) Patches, by Country USD Million (2018-2023)
  • Table 17. South America Extracellular Matrix (ECM) Patches, by Type USD Million (2018-2023)
  • Table 18. South America Extracellular Matrix (ECM) Patches, by Application USD Million (2018-2023)
  • Table 19. South America Extracellular Matrix (ECM) Patches, by End User USD Million (2018-2023)
  • Table 20. Brazil Extracellular Matrix (ECM) Patches, by Type USD Million (2018-2023)
  • Table 21. Brazil Extracellular Matrix (ECM) Patches, by Application USD Million (2018-2023)
  • Table 22. Brazil Extracellular Matrix (ECM) Patches, by End User USD Million (2018-2023)
  • Table 23. Argentina Extracellular Matrix (ECM) Patches, by Type USD Million (2018-2023)
  • Table 24. Argentina Extracellular Matrix (ECM) Patches, by Application USD Million (2018-2023)
  • Table 25. Argentina Extracellular Matrix (ECM) Patches, by End User USD Million (2018-2023)
  • Table 26. Rest of South America Extracellular Matrix (ECM) Patches, by Type USD Million (2018-2023)
  • Table 27. Rest of South America Extracellular Matrix (ECM) Patches, by Application USD Million (2018-2023)
  • Table 28. Rest of South America Extracellular Matrix (ECM) Patches, by End User USD Million (2018-2023)
  • Table 29. Asia Pacific Extracellular Matrix (ECM) Patches, by Country USD Million (2018-2023)
  • Table 30. Asia Pacific Extracellular Matrix (ECM) Patches, by Type USD Million (2018-2023)
  • Table 31. Asia Pacific Extracellular Matrix (ECM) Patches, by Application USD Million (2018-2023)
  • Table 32. Asia Pacific Extracellular Matrix (ECM) Patches, by End User USD Million (2018-2023)
  • Table 33. China Extracellular Matrix (ECM) Patches, by Type USD Million (2018-2023)
  • Table 34. China Extracellular Matrix (ECM) Patches, by Application USD Million (2018-2023)
  • Table 35. China Extracellular Matrix (ECM) Patches, by End User USD Million (2018-2023)
  • Table 36. Japan Extracellular Matrix (ECM) Patches, by Type USD Million (2018-2023)
  • Table 37. Japan Extracellular Matrix (ECM) Patches, by Application USD Million (2018-2023)
  • Table 38. Japan Extracellular Matrix (ECM) Patches, by End User USD Million (2018-2023)
  • Table 39. India Extracellular Matrix (ECM) Patches, by Type USD Million (2018-2023)
  • Table 40. India Extracellular Matrix (ECM) Patches, by Application USD Million (2018-2023)
  • Table 41. India Extracellular Matrix (ECM) Patches, by End User USD Million (2018-2023)
  • Table 42. South Korea Extracellular Matrix (ECM) Patches, by Type USD Million (2018-2023)
  • Table 43. South Korea Extracellular Matrix (ECM) Patches, by Application USD Million (2018-2023)
  • Table 44. South Korea Extracellular Matrix (ECM) Patches, by End User USD Million (2018-2023)
  • Table 45. Taiwan Extracellular Matrix (ECM) Patches, by Type USD Million (2018-2023)
  • Table 46. Taiwan Extracellular Matrix (ECM) Patches, by Application USD Million (2018-2023)
  • Table 47. Taiwan Extracellular Matrix (ECM) Patches, by End User USD Million (2018-2023)
  • Table 48. Australia Extracellular Matrix (ECM) Patches, by Type USD Million (2018-2023)
  • Table 49. Australia Extracellular Matrix (ECM) Patches, by Application USD Million (2018-2023)
  • Table 50. Australia Extracellular Matrix (ECM) Patches, by End User USD Million (2018-2023)
  • Table 51. Rest of Asia-Pacific Extracellular Matrix (ECM) Patches, by Type USD Million (2018-2023)
  • Table 52. Rest of Asia-Pacific Extracellular Matrix (ECM) Patches, by Application USD Million (2018-2023)
  • Table 53. Rest of Asia-Pacific Extracellular Matrix (ECM) Patches, by End User USD Million (2018-2023)
  • Table 54. Europe Extracellular Matrix (ECM) Patches, by Country USD Million (2018-2023)
  • Table 55. Europe Extracellular Matrix (ECM) Patches, by Type USD Million (2018-2023)
  • Table 56. Europe Extracellular Matrix (ECM) Patches, by Application USD Million (2018-2023)
  • Table 57. Europe Extracellular Matrix (ECM) Patches, by End User USD Million (2018-2023)
  • Table 58. Germany Extracellular Matrix (ECM) Patches, by Type USD Million (2018-2023)
  • Table 59. Germany Extracellular Matrix (ECM) Patches, by Application USD Million (2018-2023)
  • Table 60. Germany Extracellular Matrix (ECM) Patches, by End User USD Million (2018-2023)
  • Table 61. France Extracellular Matrix (ECM) Patches, by Type USD Million (2018-2023)
  • Table 62. France Extracellular Matrix (ECM) Patches, by Application USD Million (2018-2023)
  • Table 63. France Extracellular Matrix (ECM) Patches, by End User USD Million (2018-2023)
  • Table 64. Italy Extracellular Matrix (ECM) Patches, by Type USD Million (2018-2023)
  • Table 65. Italy Extracellular Matrix (ECM) Patches, by Application USD Million (2018-2023)
  • Table 66. Italy Extracellular Matrix (ECM) Patches, by End User USD Million (2018-2023)
  • Table 67. United Kingdom Extracellular Matrix (ECM) Patches, by Type USD Million (2018-2023)
  • Table 68. United Kingdom Extracellular Matrix (ECM) Patches, by Application USD Million (2018-2023)
  • Table 69. United Kingdom Extracellular Matrix (ECM) Patches, by End User USD Million (2018-2023)
  • Table 70. Netherlands Extracellular Matrix (ECM) Patches, by Type USD Million (2018-2023)
  • Table 71. Netherlands Extracellular Matrix (ECM) Patches, by Application USD Million (2018-2023)
  • Table 72. Netherlands Extracellular Matrix (ECM) Patches, by End User USD Million (2018-2023)
  • Table 73. Rest of Europe Extracellular Matrix (ECM) Patches, by Type USD Million (2018-2023)
  • Table 74. Rest of Europe Extracellular Matrix (ECM) Patches, by Application USD Million (2018-2023)
  • Table 75. Rest of Europe Extracellular Matrix (ECM) Patches, by End User USD Million (2018-2023)
  • Table 76. MEA Extracellular Matrix (ECM) Patches, by Country USD Million (2018-2023)
  • Table 77. MEA Extracellular Matrix (ECM) Patches, by Type USD Million (2018-2023)
  • Table 78. MEA Extracellular Matrix (ECM) Patches, by Application USD Million (2018-2023)
  • Table 79. MEA Extracellular Matrix (ECM) Patches, by End User USD Million (2018-2023)
  • Table 80. Middle East Extracellular Matrix (ECM) Patches, by Type USD Million (2018-2023)
  • Table 81. Middle East Extracellular Matrix (ECM) Patches, by Application USD Million (2018-2023)
  • Table 82. Middle East Extracellular Matrix (ECM) Patches, by End User USD Million (2018-2023)
  • Table 83. Africa Extracellular Matrix (ECM) Patches, by Type USD Million (2018-2023)
  • Table 84. Africa Extracellular Matrix (ECM) Patches, by Application USD Million (2018-2023)
  • Table 85. Africa Extracellular Matrix (ECM) Patches, by End User USD Million (2018-2023)
  • Table 86. North America Extracellular Matrix (ECM) Patches, by Country USD Million (2018-2023)
  • Table 87. North America Extracellular Matrix (ECM) Patches, by Type USD Million (2018-2023)
  • Table 88. North America Extracellular Matrix (ECM) Patches, by Application USD Million (2018-2023)
  • Table 89. North America Extracellular Matrix (ECM) Patches, by End User USD Million (2018-2023)
  • Table 90. United States Extracellular Matrix (ECM) Patches, by Type USD Million (2018-2023)
  • Table 91. United States Extracellular Matrix (ECM) Patches, by Application USD Million (2018-2023)
  • Table 92. United States Extracellular Matrix (ECM) Patches, by End User USD Million (2018-2023)
  • Table 93. Canada Extracellular Matrix (ECM) Patches, by Type USD Million (2018-2023)
  • Table 94. Canada Extracellular Matrix (ECM) Patches, by Application USD Million (2018-2023)
  • Table 95. Canada Extracellular Matrix (ECM) Patches, by End User USD Million (2018-2023)
  • Table 96. Mexico Extracellular Matrix (ECM) Patches, by Type USD Million (2018-2023)
  • Table 97. Mexico Extracellular Matrix (ECM) Patches, by Application USD Million (2018-2023)
  • Table 98. Mexico Extracellular Matrix (ECM) Patches, by End User USD Million (2018-2023)
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Extracellular Matrix (ECM) Patches: by Type(USD Million)
  • Table 110. Extracellular Matrix (ECM) Patches Bovine , by Region USD Million (2025-2030)
  • Table 111. Extracellular Matrix (ECM) Patches Porcine , by Region USD Million (2025-2030)
  • Table 112. Extracellular Matrix (ECM) Patches Others , by Region USD Million (2025-2030)
  • Table 113. Extracellular Matrix (ECM) Patches: by Application(USD Million)
  • Table 114. Extracellular Matrix (ECM) Patches Vascular Repair and Reconstruction , by Region USD Million (2025-2030)
  • Table 115. Extracellular Matrix (ECM) Patches Cardiac Repair , by Region USD Million (2025-2030)
  • Table 116. Extracellular Matrix (ECM) Patches Pericardial Repair , by Region USD Million (2025-2030)
  • Table 117. Extracellular Matrix (ECM) Patches Dural Repair , by Region USD Million (2025-2030)
  • Table 118. Extracellular Matrix (ECM) Patches Soft Tissue Repair , by Region USD Million (2025-2030)
  • Table 119. Extracellular Matrix (ECM) Patches Wound Healing , by Region USD Million (2025-2030)
  • Table 120. Extracellular Matrix (ECM) Patches: by End User(USD Million)
  • Table 121. Extracellular Matrix (ECM) Patches Hospitals , by Region USD Million (2025-2030)
  • Table 122. Extracellular Matrix (ECM) Patches Surgical Clinics , by Region USD Million (2025-2030)
  • Table 123. Extracellular Matrix (ECM) Patches Others , by Region USD Million (2025-2030)
  • Table 124. South America Extracellular Matrix (ECM) Patches, by Country USD Million (2025-2030)
  • Table 125. South America Extracellular Matrix (ECM) Patches, by Type USD Million (2025-2030)
  • Table 126. South America Extracellular Matrix (ECM) Patches, by Application USD Million (2025-2030)
  • Table 127. South America Extracellular Matrix (ECM) Patches, by End User USD Million (2025-2030)
  • Table 128. Brazil Extracellular Matrix (ECM) Patches, by Type USD Million (2025-2030)
  • Table 129. Brazil Extracellular Matrix (ECM) Patches, by Application USD Million (2025-2030)
  • Table 130. Brazil Extracellular Matrix (ECM) Patches, by End User USD Million (2025-2030)
  • Table 131. Argentina Extracellular Matrix (ECM) Patches, by Type USD Million (2025-2030)
  • Table 132. Argentina Extracellular Matrix (ECM) Patches, by Application USD Million (2025-2030)
  • Table 133. Argentina Extracellular Matrix (ECM) Patches, by End User USD Million (2025-2030)
  • Table 134. Rest of South America Extracellular Matrix (ECM) Patches, by Type USD Million (2025-2030)
  • Table 135. Rest of South America Extracellular Matrix (ECM) Patches, by Application USD Million (2025-2030)
  • Table 136. Rest of South America Extracellular Matrix (ECM) Patches, by End User USD Million (2025-2030)
  • Table 137. Asia Pacific Extracellular Matrix (ECM) Patches, by Country USD Million (2025-2030)
  • Table 138. Asia Pacific Extracellular Matrix (ECM) Patches, by Type USD Million (2025-2030)
  • Table 139. Asia Pacific Extracellular Matrix (ECM) Patches, by Application USD Million (2025-2030)
  • Table 140. Asia Pacific Extracellular Matrix (ECM) Patches, by End User USD Million (2025-2030)
  • Table 141. China Extracellular Matrix (ECM) Patches, by Type USD Million (2025-2030)
  • Table 142. China Extracellular Matrix (ECM) Patches, by Application USD Million (2025-2030)
  • Table 143. China Extracellular Matrix (ECM) Patches, by End User USD Million (2025-2030)
  • Table 144. Japan Extracellular Matrix (ECM) Patches, by Type USD Million (2025-2030)
  • Table 145. Japan Extracellular Matrix (ECM) Patches, by Application USD Million (2025-2030)
  • Table 146. Japan Extracellular Matrix (ECM) Patches, by End User USD Million (2025-2030)
  • Table 147. India Extracellular Matrix (ECM) Patches, by Type USD Million (2025-2030)
  • Table 148. India Extracellular Matrix (ECM) Patches, by Application USD Million (2025-2030)
  • Table 149. India Extracellular Matrix (ECM) Patches, by End User USD Million (2025-2030)
  • Table 150. South Korea Extracellular Matrix (ECM) Patches, by Type USD Million (2025-2030)
  • Table 151. South Korea Extracellular Matrix (ECM) Patches, by Application USD Million (2025-2030)
  • Table 152. South Korea Extracellular Matrix (ECM) Patches, by End User USD Million (2025-2030)
  • Table 153. Taiwan Extracellular Matrix (ECM) Patches, by Type USD Million (2025-2030)
  • Table 154. Taiwan Extracellular Matrix (ECM) Patches, by Application USD Million (2025-2030)
  • Table 155. Taiwan Extracellular Matrix (ECM) Patches, by End User USD Million (2025-2030)
  • Table 156. Australia Extracellular Matrix (ECM) Patches, by Type USD Million (2025-2030)
  • Table 157. Australia Extracellular Matrix (ECM) Patches, by Application USD Million (2025-2030)
  • Table 158. Australia Extracellular Matrix (ECM) Patches, by End User USD Million (2025-2030)
  • Table 159. Rest of Asia-Pacific Extracellular Matrix (ECM) Patches, by Type USD Million (2025-2030)
  • Table 160. Rest of Asia-Pacific Extracellular Matrix (ECM) Patches, by Application USD Million (2025-2030)
  • Table 161. Rest of Asia-Pacific Extracellular Matrix (ECM) Patches, by End User USD Million (2025-2030)
  • Table 162. Europe Extracellular Matrix (ECM) Patches, by Country USD Million (2025-2030)
  • Table 163. Europe Extracellular Matrix (ECM) Patches, by Type USD Million (2025-2030)
  • Table 164. Europe Extracellular Matrix (ECM) Patches, by Application USD Million (2025-2030)
  • Table 165. Europe Extracellular Matrix (ECM) Patches, by End User USD Million (2025-2030)
  • Table 166. Germany Extracellular Matrix (ECM) Patches, by Type USD Million (2025-2030)
  • Table 167. Germany Extracellular Matrix (ECM) Patches, by Application USD Million (2025-2030)
  • Table 168. Germany Extracellular Matrix (ECM) Patches, by End User USD Million (2025-2030)
  • Table 169. France Extracellular Matrix (ECM) Patches, by Type USD Million (2025-2030)
  • Table 170. France Extracellular Matrix (ECM) Patches, by Application USD Million (2025-2030)
  • Table 171. France Extracellular Matrix (ECM) Patches, by End User USD Million (2025-2030)
  • Table 172. Italy Extracellular Matrix (ECM) Patches, by Type USD Million (2025-2030)
  • Table 173. Italy Extracellular Matrix (ECM) Patches, by Application USD Million (2025-2030)
  • Table 174. Italy Extracellular Matrix (ECM) Patches, by End User USD Million (2025-2030)
  • Table 175. United Kingdom Extracellular Matrix (ECM) Patches, by Type USD Million (2025-2030)
  • Table 176. United Kingdom Extracellular Matrix (ECM) Patches, by Application USD Million (2025-2030)
  • Table 177. United Kingdom Extracellular Matrix (ECM) Patches, by End User USD Million (2025-2030)
  • Table 178. Netherlands Extracellular Matrix (ECM) Patches, by Type USD Million (2025-2030)
  • Table 179. Netherlands Extracellular Matrix (ECM) Patches, by Application USD Million (2025-2030)
  • Table 180. Netherlands Extracellular Matrix (ECM) Patches, by End User USD Million (2025-2030)
  • Table 181. Rest of Europe Extracellular Matrix (ECM) Patches, by Type USD Million (2025-2030)
  • Table 182. Rest of Europe Extracellular Matrix (ECM) Patches, by Application USD Million (2025-2030)
  • Table 183. Rest of Europe Extracellular Matrix (ECM) Patches, by End User USD Million (2025-2030)
  • Table 184. MEA Extracellular Matrix (ECM) Patches, by Country USD Million (2025-2030)
  • Table 185. MEA Extracellular Matrix (ECM) Patches, by Type USD Million (2025-2030)
  • Table 186. MEA Extracellular Matrix (ECM) Patches, by Application USD Million (2025-2030)
  • Table 187. MEA Extracellular Matrix (ECM) Patches, by End User USD Million (2025-2030)
  • Table 188. Middle East Extracellular Matrix (ECM) Patches, by Type USD Million (2025-2030)
  • Table 189. Middle East Extracellular Matrix (ECM) Patches, by Application USD Million (2025-2030)
  • Table 190. Middle East Extracellular Matrix (ECM) Patches, by End User USD Million (2025-2030)
  • Table 191. Africa Extracellular Matrix (ECM) Patches, by Type USD Million (2025-2030)
  • Table 192. Africa Extracellular Matrix (ECM) Patches, by Application USD Million (2025-2030)
  • Table 193. Africa Extracellular Matrix (ECM) Patches, by End User USD Million (2025-2030)
  • Table 194. North America Extracellular Matrix (ECM) Patches, by Country USD Million (2025-2030)
  • Table 195. North America Extracellular Matrix (ECM) Patches, by Type USD Million (2025-2030)
  • Table 196. North America Extracellular Matrix (ECM) Patches, by Application USD Million (2025-2030)
  • Table 197. North America Extracellular Matrix (ECM) Patches, by End User USD Million (2025-2030)
  • Table 198. United States Extracellular Matrix (ECM) Patches, by Type USD Million (2025-2030)
  • Table 199. United States Extracellular Matrix (ECM) Patches, by Application USD Million (2025-2030)
  • Table 200. United States Extracellular Matrix (ECM) Patches, by End User USD Million (2025-2030)
  • Table 201. Canada Extracellular Matrix (ECM) Patches, by Type USD Million (2025-2030)
  • Table 202. Canada Extracellular Matrix (ECM) Patches, by Application USD Million (2025-2030)
  • Table 203. Canada Extracellular Matrix (ECM) Patches, by End User USD Million (2025-2030)
  • Table 204. Mexico Extracellular Matrix (ECM) Patches, by Type USD Million (2025-2030)
  • Table 205. Mexico Extracellular Matrix (ECM) Patches, by Application USD Million (2025-2030)
  • Table 206. Mexico Extracellular Matrix (ECM) Patches, by End User USD Million (2025-2030)
  • Table 207. Research Programs/Design for This Report
  • Table 208. Key Data Information from Secondary Sources
  • Table 209. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Extracellular Matrix (ECM) Patches: by Type USD Million (2018-2023)
  • Figure 5. Global Extracellular Matrix (ECM) Patches: by Application USD Million (2018-2023)
  • Figure 6. Global Extracellular Matrix (ECM) Patches: by End User USD Million (2018-2023)
  • Figure 7. South America Extracellular Matrix (ECM) Patches Share (%), by Country
  • Figure 8. Asia Pacific Extracellular Matrix (ECM) Patches Share (%), by Country
  • Figure 9. Europe Extracellular Matrix (ECM) Patches Share (%), by Country
  • Figure 10. MEA Extracellular Matrix (ECM) Patches Share (%), by Country
  • Figure 11. North America Extracellular Matrix (ECM) Patches Share (%), by Country
  • Figure 12. Global Extracellular Matrix (ECM) Patches share by Players 2023 (%)
  • Figure 13. Global Extracellular Matrix (ECM) Patches share by Players (Top 3) 2023(%)
  • Figure 14. Global Extracellular Matrix (ECM) Patches share by Players (Top 5) 2023(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Smith & Nephew plc (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 17. Smith & Nephew plc (United Kingdom) Revenue: by Geography 2023
  • Figure 18. Boston Scientific Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 19. Boston Scientific Corporation (United States) Revenue: by Geography 2023
  • Figure 20. Koninklijke DSM N.V. (Netherlands) Revenue, Net Income and Gross profit
  • Figure 21. Koninklijke DSM N.V. (Netherlands) Revenue: by Geography 2023
  • Figure 22. Coloplast A/S (Denmark) Revenue, Net Income and Gross profit
  • Figure 23. Coloplast A/S (Denmark) Revenue: by Geography 2023
  • Figure 24. Cook Group (United States) Revenue, Net Income and Gross profit
  • Figure 25. Cook Group (United States) Revenue: by Geography 2023
  • Figure 26. MTF Biologics (United States) Revenue, Net Income and Gross profit
  • Figure 27. MTF Biologics (United States) Revenue: by Geography 2023
  • Figure 28. Medtronic plc (Ireland) Revenue, Net Income and Gross profit
  • Figure 29. Medtronic plc (Ireland) Revenue: by Geography 2023
  • Figure 30. Baxter International Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 31. Baxter International Inc. (United States) Revenue: by Geography 2023
  • Figure 32. Aziyo Biologics, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 33. Aziyo Biologics, Inc. (United States) Revenue: by Geography 2023
  • Figure 34. Admedus Ltd. (Australia) Revenue, Net Income and Gross profit
  • Figure 35. Admedus Ltd. (Australia) Revenue: by Geography 2023
  • Figure 36. Global Extracellular Matrix (ECM) Patches: by Type USD Million (2025-2030)
  • Figure 37. Global Extracellular Matrix (ECM) Patches: by Application USD Million (2025-2030)
  • Figure 38. Global Extracellular Matrix (ECM) Patches: by End User USD Million (2025-2030)
  • Figure 39. South America Extracellular Matrix (ECM) Patches Share (%), by Country
  • Figure 40. Asia Pacific Extracellular Matrix (ECM) Patches Share (%), by Country
  • Figure 41. Europe Extracellular Matrix (ECM) Patches Share (%), by Country
  • Figure 42. MEA Extracellular Matrix (ECM) Patches Share (%), by Country
  • Figure 43. North America Extracellular Matrix (ECM) Patches Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Smith & Nephew plc (United Kingdom)
  • Boston Scientific Corporation (United States)
  • Koninklijke DSM N.V. (Netherlands)
  • Coloplast A/S (Denmark)
  • Cook Group (United States)
  • MTF Biologics (United States)
  • Medtronic plc (Ireland)
  • Baxter International Inc. (United States)
  • Aziyo Biologics, Inc. (United States)
  • Admedus Ltd. (Australia)
Additional players considered in the study are as follows:
JZ Healthcare (Shanghai) Co., Ltd. (China) , Orthox Regenerative Technologies Plc (United Kingdom) , Medtronic China (China) , KCI Licensing Inc. (Texas) ,
Select User Access Type

Key Highlights of Report


Jan 2024 211 Pages 89 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Extracellular Matrix (ECM) Patches Quantitative research analysis
Global Extracellular Matrix (ECM) Patches Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Smith & Nephew plc (United Kingdom), Boston Scientific Corporation (United States), Koninklijke DSM N.V. (Netherlands), Coloplast A/S (Denmark), Cook Group (United States), MTF Biologics (United States), Medtronic plc (Ireland), Baxter International Inc. (United States), Aziyo Biologics, Inc. (United States) and Admedus Ltd. (Australia) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Trend for Bovine-based ECM Patches" is seen as one of major influencing trends for Extracellular Matrix (ECM) Patches Market during projected period 2023-2030.
The Extracellular Matrix (ECM) Patches market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Extracellular Matrix (ECM) Patches Report?

Have a Query? Click Here

Other Related Reports

Drug Test Cup Comprehensive Study by Type (Test Cups,, Test Strips,, Others Source.), Application (Drug Testing In Workplace, Employee Drug Testing, Border Control, Roadside Drug Testing, Cholinester...
$ 3750
Biliary Stents Comprehensive Study by Type (Metal Stents, Plastic Stents), Application (Hospitals, ASCs, Others) Players and Region - Global Market Outlook to 2024
$ 3500
Brain Mapping Instruments Comprehensive Study by Type (Computed Tomography, Positron Emission Tomography, Electroencephalography, Magnetoencephalography, Other), Application (Hospitals, Neurological ...
$ 3650
Medical Drones Comprehensive Study by Drone Type (Multi Rotor Drones, Fixed Wing Drones, Others), Medical Application (Acute Care, Vaccination Programs, Blood bank Transferring, Drug/Pharmaceutical ...
$ 3650
Urinalysis Devices Comprehensive Study by Type (Macroscopic Urinalysis Devices, Sediments/Microscopic Urinalysis Devices, Other), Application (Urinary Tract Infections, Kidney Diseases, Diabetes, Liv...
$ 3750
Catheter Comprehensive Study by Type (Straight Nelaton Catheter, Two‐way Foley Catheter, Three‐way Foley, Coude Tip and Tiemann, Suprapubic, Others), Length (Standard (41-45cm), Female (2...
$ 3750